who: . et al. from the Changchun Institute of Applied Chemistry (CAS), China Fourth Military Medical University, China have published the paper: Engineering exosomes for bone defect repair, in the Journal: (JOURNAL)
SUMMARY
The regeneration of criticalsize bone defects is still a major clinical challenge and globally costs up to $45 billion per year (Mauffrey et_al, 2015; Bharadwaz and Jayasuriya, 2020). Stem_cell therapy is considered as a potential strategy for bone defect regeneration (Tan SHS. et_al, 2020), and several clinical studies have demonstrated mesenchymal stromal/stem_cells (MSCs) to be safe and efficacious for the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.
